Literature DB >> 24569585

Quantitative analysis of fluorescence lifetime measurements of the macula using the fluorescence lifetime imaging ophthalmoscope in healthy subjects.

Chantal Dysli1, Gwénolé Quellec, Mathias Abegg, Marcel N Menke, Ute Wolf-Schnurrbusch, Jens Kowal, Johannes Blatz, Olivier La Schiazza, Alexander B Leichtle, Sebastian Wolf, Martin S Zinkernagel.   

Abstract

PURPOSE: Fundus autofluorescence (FAF) cannot only be characterized by the intensity or the emission spectrum, but also by its lifetime. As the lifetime of a fluorescent molecule is sensitive to its local microenvironment, this technique may provide more information than fundus autofluorescence imaging. We report here the characteristics and repeatability of FAF lifetime measurements of the human macula using a new fluorescence lifetime imaging ophthalmoscope (FLIO).
METHODS: A total of 31 healthy phakic subjects were included in this study with an age range from 22 to 61 years. For image acquisition, a fluorescence lifetime ophthalmoscope based on a Heidelberg Engineering Spectralis system was used. Fluorescence lifetime maps of the retina were recorded in a short- (498-560 nm) and a long- (560-720 nm) spectral channel. For quantification of fluorescence lifetimes a standard ETDRS grid was used.
RESULTS: Mean fluorescence lifetimes were shortest in the fovea, with 208 picoseconds for the short-spectral channel and 239 picoseconds for the long-spectral channel, respectively. Fluorescence lifetimes increased from the central area to the outer ring of the ETDRS grid. The test-retest reliability of FLIO was very high for all ETDRS areas (Spearman's ρ = 0.80 for the short- and 0.97 for the long-spectral channel, P < 0.0001). Fluorescence lifetimes increased with age.
CONCLUSIONS: The FLIO allows reproducible measurements of fluorescence lifetimes of the macula in healthy subjects. By using a custom-built software, we were able to quantify fluorescence lifetimes within the ETDRS grid. Establishing a clinically accessible standard against which to measure FAF lifetimes within the retina is a prerequisite for future studies in retinal disease.

Entities:  

Keywords:  fluorescence lifetimes; fundus autofluorescence; macula; validation studies

Mesh:

Year:  2014        PMID: 24569585     DOI: 10.1167/iovs.13-13627

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  32 in total

1.  Decrease in fluorescence lifetime by glycation of collagen and its application in determining advanced glycation end-products in human dentin.

Authors:  Shuichiro Fukushima; Masato Shimizu; Jiro Miura; Yusuke Matsuda; Mizuho Kubo; Mamoru Hashimoto; Takuya Aoki; Fumio Takeshige; Tsutomu Araki
Journal:  Biomed Opt Express       Date:  2015-04-23       Impact factor: 3.732

2.  Fundus autofluorescence beyond lipofuscin: lesson learned from ex vivo fluorescence lifetime imaging in porcine eyes.

Authors:  Martin Hammer; Lydia Sauer; Matthias Klemm; Sven Peters; Rowena Schultz; Jens Haueisen
Journal:  Biomed Opt Express       Date:  2018-06-11       Impact factor: 3.732

3.  Simplified approach to least-square fitting of fluorescence lifetime ophthalmoscopy (FLIO) data by fixating lifetimes.

Authors:  Rowena Schultz; Franziska Schuster; Thomas Lehmann; Johanna Schmidt; Regine Augsten; Martin Hammer
Journal:  Biomed Opt Express       Date:  2019-11-01       Impact factor: 3.732

4.  Spectral analysis of fundus autofluorescence pattern as a tool to detect early stages of degeneration in the retina and retinal pigment epithelium.

Authors:  Tatiana B Feldman; Marina A Yakovleva; Andrey V Larichev; Patimat M Arbukhanova; Alexandra Sh Radchenko; Sergey A Borzenok; Vladimir A Kuzmin; Mikhail A Ostrovsky
Journal:  Eye (Lond)       Date:  2018-05-22       Impact factor: 3.775

5.  Ocular Imaging for Enhancing the Understanding, Assessment, and Management of Age-Related Macular Degeneration.

Authors:  Marco Nassisi; Srinivas R Sadda
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Adaptive optics fluorescence lifetime imaging ophthalmoscopy of in vivo human retinal pigment epithelium.

Authors:  Janet A H Tang; Charles E Granger; Karteek Kunala; Keith Parkins; Khang T Huynh; Kristen Bowles-Johnson; Qiang Yang; Jennifer J Hunter
Journal:  Biomed Opt Express       Date:  2022-02-25       Impact factor: 3.732

7.  Repeatability of Fluorescence Lifetime Imaging Ophthalmoscopy in Normal Subjects With Mydriasis.

Authors:  Soonil Kwon; Enrico Borrelli; Wenying Fan; Adel Ebraheem; Kenneth M Marion; SriniVas R Sadda
Journal:  Transl Vis Sci Technol       Date:  2019-05-08       Impact factor: 3.283

8.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

9.  FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS.

Authors:  Lydia Sauer; Alexandra S Vitale; Karl M Andersen; Barbara Hart; Paul S Bernstein
Journal:  Retina       Date:  2020-04       Impact factor: 3.975

10.  Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases.

Authors:  Lukas Goerdt; Lydia Sauer; Alexandra S Vitale; Natalie K Modersitzki; Monika Fleckenstein; Paul S Bernstein
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.